NDRA (STOCKS)
ENDRA Life Sciences Inc. Common Stock
$5.170000
+0.230000 (+4.66%)
Prev close: $4.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Alexander Y. Tokman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.44M
- Employees
- 16
- P/E (TTM)
- -0.58
- P/B (TTM)
- 2.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-3.26 | $-1.25 | -2.0054 | -159.84% |
|
Sep 2025 (Q3)
|
$-2.10 | $-1.99 | -0.1110 | -5.58% |
|
Jun 2025 (Q2)
|
$-1.71 | $-2.32 | +0.6054 | +26.15% |
|
Mar 2025 (Q1)
|
$-1.86 | $-3.99 | +2.1282 | +53.36% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.26M |
| Operating Expenses | $5.76M |
| Research and Development | $1.85M |
| Other Operating Expenses | $3.91M |
| Operating Income/Loss | -$5.76M |
| Income/Loss From Continuing Operations After Tax | -$7.03M |
| Income/Loss From Continuing Operations Before Tax | -$7.03M |
| Net Income/Loss | -$7.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.93 |
| Diluted Earnings Per Share | -$8.93 |
| Basic Average Shares | 787,020 |
| Diluted Average Shares | 787,020 |
| Assets | $3.85M |
| Current Assets | $967.97K |
| Inventory | $0.00 |
| Prepaid Expenses | $205.60K |
| Other Current Assets | $762.37K |
| Noncurrent Assets | $2.89M |
| Fixed Assets | $42.52K |
| Non-current Prepaid Expenses | $365.42K |
| Other Non-current Assets | $2.48M |
| Liabilities | $1.59M |
| Current Liabilities | $750.96K |
| Accounts Payable | $382.97K |
| Wages | $70.97K |
| Other Current Liabilities | $297.02K |
| Noncurrent Liabilities | $842.72K |
| Equity | $2.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.26M |
| Liabilities And Equity | $3.85M |
| Net Cash Flow From Operating Activities | -$5.18M |
| Net Cash Flow From Operating Activities, Continuing | -$5.18M |
| Net Cash Flow From Investing Activities | -$3.02M |
| Net Cash Flow From Investing Activities, Continuing | -$3.02M |
| Net Cash Flow From Financing Activities | $5.73M |
| Net Cash Flow From Financing Activities, Continuing | $5.73M |
| Net Cash Flow | -$2.47M |
| Net Cash Flow, Continuing | -$2.47M |
| Comprehensive Income/Loss | -$7.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.03M |
| Other Comprehensive Income/Loss | $0.00 |